[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016-2020 Italy Clinical Chemistry and Immunodiagnostic Markets: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

March 2016 | 561 pages | ID: 2DBA0779E98EN
Venture Planning Group

US$ 4,880.00 US$ 6,100.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the Italian clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the German market; provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.

This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators. Strategic Recommendations
  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.Competitive Assessments
  • Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
  • The companies analyzed in the report include Abbott, AdnaGen, Agilent, Alere, Beckman Coulter/Danaher, Biomedical Diagnostics, bioMerieux, Bio-Rad, DiaSorin, Eiken, Fujirebio, Grifols, IL, Kyowa Medex, Matritech/Alere, Ortho-Clinical Diagnostics, Roche, Siemens, Sysmex, Thermo Fisher, Tosoh, Wako, Wallac/PE. Tests Analyzed in the Report: Routine Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid. Therapeutic Drug Monitoring (TDM) Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin. Endocrine Function Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH. Tumor Markers and Special Chemistry AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12. Immunoproteins C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis. Drugs of Abuse Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.Market Segmentation Analysis
  • Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.
  • Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by market segment: Hospitals Commercial/Private Laboratories Current and Emerging Products
  • Analysis of current and emerging clinical chemistry and immunodiagnostic tests.
  • Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.Technology Review
  • Assessment of current and emerging technologies, and their potential market applications.
  • Comprehensive lists of companies developing or marketing new technologies and products by test.

    Contains 561 pages and 103 tables
  • 1. INTRODUCTION

    2. WORLDWIDE MARKET OVERVIEW

    1. BUSINESS ENVIRONMENT
    2. MARKET STRUCTURE
    3. MARKET SIZE AND GROWTH

    3. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    4. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    5. ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets

    6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    7. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

    A. Major Routine Chemistry Tests
      1. ALBUMIN
      2. ALKALINE PHOSPHATASE
      3. ALT/SGPT
      4. AMMONIA
      5. AMYLASE
      6. AST/SGOT
      7. BILIRUBIN, TOTAL
      8. BLOOD GASES
      9. BLOOD UREA NITROGEN (BUN)
      10. CALCIUM
      11. CARDIO CRP
      12. CHOLESTEROL
      13. CHOLINESTERASE
      14. CRP
      15. CREATININE
      16. ELECTROLYTES
        a. Carbon Dioxide/Bicarbonate
        b. Chloride
        c. Potassium
        d. Sodium
      17. FERRITIN
      18. FRUCTOSAMINE
      19. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
      20. GLUCOSE
      21. HIGH DENSITY LIPOPROTEIN (HDL)
      22. HOMOCYSTEINE
      23. IRON
      24. LACTATE DEHYDROGENASE (LDH)
      25. MAGNESIUM
      26. PHOSPHORUS
      27. PROTEIN
      28. TRIGLYCERIDES
      29. URIC ACID
      30. TROPONIN
    B. Therapeutic Drug Monitoring (TDM)
      1. OVERVIEW
      2. CARBAMAZEPINE
      3. CYCLOSPORIN
      4. DIGOXIN
      5. EVEROLIMUS
      6. GENTAMICIN
      7. LAMOTRIGINE/LAMICTAL
      8. LEVETIRACETAM
      9. LIDOCAINE
      10. LITHIUM
      11. NAPA/PROCAINAMIDE
      12. PHENYTOIN
      13. QUINIDINE
      14. SIROLIMUS
      15. TACROLIMUS
      16. THEOPHYLLINE
      17. TOPIRIMATE
      18. VALPROIC ACID
    C. Endocrine Function Tests
      1. CORTISOL
      2. ESTRADIOL
      3. FOLLICLE-STIMULATING HORMONE (FSH)
      4. GASTRIN
      5. GROWTH HORMONE/IGF-1
      6. HUMAN CHORIONIC GONADOTROPIN (HCG)
      7. LH
      8. PROGESTERONE
      9. PTH/IO PTH
      10. PROLACTIN
      11. T3
      12. T3 FREE
      13. T3 UPTAKE
      14. T4 (THYROXINE)
      15. T4 FREE
      16. TBG
      17. TESTOSTERONE
      18. THYROGLOBULIN AB
      19. TPO AB
      20. TSH
    D. Tumor Markers and Special Chemistry Tests
      1. AFP
      2. CA 15-3
      3. CA 19-9
      4. CA 27-29
      5. CARCINOEMBRIONIC ANTIGEN (CEA)
      6. FOLATE/FOLIC ACID
      7. HCG
      8. 25-HYDROXY VITAMIN D2 AND D3
      9. OCCULT BLOOD
      10. PROSTATE-SPECIFIC ANTIGEN (PSA)
      11. THYROGLOBULIN
      12. VITAMIN B-12
    E. Immunoprotein Tests
      1. COMPLEMENT
        a. C3
        b. C4
      2. FREE LIGHT CHAINS
      3. IMMUNOFIXATION
      4. IMMUNOGLOBULINS (IGA, IGE, IGG, IGM)
      5. HAPTOGLOBIN
      6. PREALBUMIN
      7. PROTEIN ELECTROPHORESIS
    F. Drugs of Abuse
      1. OVERVIEW
      2. TEST METHODOLOGIES
      3. AMPHETAMINES
      4. BARBITURATES
      5. BENZODIAZEPINES
      6. CANNABINOIDS/MARIJUANA
      7. COCAINE
      8. LYSERGIC ACID DIETHYLAMIDE (LSD)
      9. METHADONE
      10. METHAQUALONE
      11. OPIATES
      12. PHENCYCLIDINE
      13. TRICYCLIC ANTIDEPRESSANTS
    G. Clinical Chemistry and Immunodiagnostic Instrumentation Review: operating characteristics and features of high-, medium-, and low-volume/POC analyzers
    H. Major Cliinical Chemistry and Immunodiagnostic Technologies and Their Potential Applications
      1. MONOCLONAL AND POLYCLONAL ANTIBODIES
      2. IMMUNOASSAYS
      3. TANDEM MASS SPEC
      4. IT AND AUTOMATION
      5. DRY CHEMISTRY
      6. BIOSENSORS

    8. ITALY CLINICAL CHEMISTRY AND IMMUNODIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument, Reagent Sales and Market Shares

    9. COMPETITIVE ASSESSMENTS

    Abbott Laboratories
    AdnaGen/Alere
    Agilent Technologies
    Bayer Healthcare
    Beckman Coulter/Danaher
    Biomedical Diagnostics
    BioMerieux
    Bio-Rad
    DiaSorin
    Eiken
    Fujirebio
    Grifols
    Instrumentation Laboratory
    Kyowa Medex
    Matritech/Alere
    Ortho-Clinical Diagnostics
    Quest Diagnostics
    Roche
    Siemens
    Sysmex
    Thermo Fisher
    Tosoh
    Wako
    Wallac/PE

    LIST OF TABLES

    Major Companies Developing or Marketing Albumin Tests
    Major Companies Developing or Marketing Alkaline Phosphatase Tests
    Major Companies Developing or Marketing ALT/SGPT Tests
    Major Companies Developing or Marketing Amylase Tests
    Major Companies Developing or Marketing AST/SGOT Tests
    Major Companies Developing or Marketing Bilirubin Tests
    Major Companies Developing or Marketing Blood Gas Analyzers
    Major Companies Developing or Marketing BUN Tests
    Major Companies Developing or Marketing Calcium Tests
    Major Companies Developing or Marketing Cholesterol Tests
    Major Companies Developing or Marketing Creatinine Tests
    Major Companies Developing or Marketing Electrolyte Tests
    Major Companies Developing or Marketing GGT Tests
    Major Companies Developing or Marketing Glucose Tests
    Major Companies Developing or Marketing HDL Tests
    Major Companies Developing or Marketing Iron Tests
    Major Companies Developing or Marketing LDH Tests
    Major Companies Developing or Marketing Magnesium Tests
    Major Companies Developing or Marketing Phosphorus Tests
    Major Companies Developing or Marketing Protein Tests
    Major Companies Developing or Marketing Triglycerides Tests
    Major Companies Developing or Marketing Uric Acid Tests
    Major Companies Developing or Marketing TDM Tests
    Major Companies Developing or Marketing Digoxin Tests
    Major Companies Developing or Marketing Lithium Tests
    Major Companies Developing or Marketing Phenytoin/Dilantin Tests
    Major Companies Developing or Marketing Theophylline Tests
    Major Companies Developing or Marketing Valproic Acid Tests
    Major Companies Developing or Marketing FSH Tests
    Major Companies Developing or Marketing HCG Tests
    Major Companies Developing or Marketing LH Tests
    Major Companies Developing or Marketing Prolactin Tests
    Major Companies Developing or Marketing T3 Tests
    Major Companies Developing or Marketing T4 Tests
    Major Companies Developing or Marketing TSH Tests
    Major Companies Developing or Marketing AFP Tests
    Major Companies Developing or Marketing CEA Tests
    Major Companies Developing or Marketing Ferritin Tests
    Major Companies Developing or Marketing Occult Blood Tests
    Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
    Major Companies Developing or Marketing PSA Tests
    Major Companies Developing or Marketing Vitamin B-12/Folate Tests
    Major Companies Developing or Marketing CRP Tests
    Major Companies Developing or Marketing Drugs of Abuse Tests
    Major Companies Developing or Marketing Biosensors for Immunological Testing
    Executive Summary Table: Italy, Clinical Chemistry and Immunoassay Test Volume and Diagnostics Sales Forecast By Test Category
    Italy, Laboratories Performing Chemistry and Immunoassay Tests By Market Segment
    Italy, Hospital Laboratories Performing Chemistry and Immunoassay Tests By Bed Size
    Italy, Commercial/Private Laboratories Performing Chemistry and Immunoassay Tests By Annual Test Volume
    Italy, Total Chemistry and Immunoassay Specimen Volume Forecast
    Italy, All Market Segments, Specimen Volume Forecast By Test Category
    Italy, Total Clinical Chemistry and Immunoassay Test Volume Forecast By Test Category
    Italy, Routine Chemistry Test Volume Forecast By Market Segment
    Italy, Endocrine Function Test Volume Forecast By Market Segment
    Italy, Tumor Markers and Special Chemistry Test Volume Forecast By Market Segment
    Italy, Immunoprotein Test Volume Forecast By Market Segment
    Italy, TDM Test Volume Forecast By Market Segment
    Italy, Drugs of Abuse Test Volume Forecast By Market Segment
    Italy, All Market Segments, Profiles, Panels and Individual Tests Forecast
    Italy, Hospital Laboratories, Profiles, Panels and Individual Tests Forecast
    Italy, Commercial/Private Laboratories, Profiles, Panels and Individual Tests Forecast
    Italy, All Market Segments, Routine Chemistry Test Volume Forecast by Assay
    Italy, Hospital Laboratories, Routine Chemistry Test Volume Forecast by Assay
    Italy, Commercial/Private Laboratories, Routine Chemistry Test Volume Forecast by Assay
    Italy, All Market Segments, Endocrine Function Test Volume Forecast by Assay
    Italy, Hospital Laboratories, Endocrine Function Test Volume Forecast by Assay
    Italy, Commercial/Private Laboratories, Endocrine Function Test Volume Forecast by Assay
    Italy, All Market Segments, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
    Italy, Hospital Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
    Italy, Commercial/Private Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
    Italy, All Market Segments, Immunoprotein Test Volume Forecast by Assay
    Italy, Hospital Laboratories, Immunoprotein Test Volume Forecast by Assay
    Italy, Commercial/Private Laboratories, Immunoprotein Test Volume Forecast by Assay
    Italy, All Market Segments, TDM Test Volume Forecast by Assay
    Italy, Hospital Laboratories, TDM Test Volume Forecast by Assay
    Italy, Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
    Italy, All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
    Italy, Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
    Italy, Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
    Italy, Total Clinical Chemistry and Immunoassay Reagent Market Forecast By Test Category
    Italy, Clinical Chemistry and Immunoassay Calibrator and Control Market Forecast By Test Category
    Italy, Routine Chemistry Reagent Market Forecast By Market Segment
    Italy, Endocrine Function Reagent Market Forecast By Market Segment
    Italy, Tumor Markers and Special Chemistry Reagent Market Forecast By Market Segment
    Italy, TDM Reagent Market Forecast By Market Segment
    Italy, Immunoprotein Reagent Market Forecast By Market Segment
    Italy, Drugs of Abuse Reagent Market Forecast By Market Segment
    Italy, All Market Segments, Routine Chemistry Reagent Market Forecast by Assay
    Italy, Hospital Laboratories, Routine Chemistry Reagent Market Forecast by Assay
    Italy, Commercial/Private Laboratories, Routine Chemistry Reagent Market Forecast by Assay
    Italy, All Market Segments, Endocrine Function Reagent Market Forecast by Assay
    Italy, Hospital Laboratories, Endocrine Function Reagent Market Forecast by Assay
    Italy, Commercial/Private Laboratories, Endocrine Function Reagent Market Forecast by Assay
    Italy, All Market Segments, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
    Italy, Hospital Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
    Italy, Commercial/Private Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay by Assay
    Italy, All Market Segments, Immunoprotein Reagent Market Forecast by Assay
    Italy, Hospital Laboratories, Immunoprotein Reagent Market Forecast by Assay
    Italy, Commercial/Private Laboratories, Immunoprotein Reagent Market Forecast by Assay
    Italy, All Market Segments, TDM Reagent Market Forecast by Assay
    Italy, Hospital Laboratories, TDM Reagent Market Forecast by Assay
    Italy, Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
    Italy, All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
    Italy, Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
    Italy, Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
    Italy, Clinical Chemistry and Immunoassay Instrument Market Forecast By Analyzer Type
    Italy, Major Suppliers of Clinical Chemistry Diagnostics Products, Estimated Sales and Market Shares
    Italy, Major Suppliers of Immunoassay Diagnostic Products, Estimated Sales and Market Shares


    More Publications